Optometry News

Bausch + Lomb introduced its Infuse for Astigmatism silicone hydrogel daily disposable contact lens in the United States.

PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Michael Singer, MD, discusses a phase 2a study on ANXV in treatment-naive patients with retinal vein occlusion.

Improvements in multiple sign efficacy endpoints were reported for licaminlimab in patients with dry eye disease, with more pronounced effects in patients with a TNFR1 genetic biomarker, according to an Oculis press release.

For the multi-society sustainability initiative EyeSustain, one of its biggest goals has been to collaborate with industry to reduce waste and ophthalmology’s carbon footprint.

The AMA adopted policies to protect patients’ access to necessary health care in a variety of ways at its annual meeting.

PARK CITY, Utah — In this Healio Video Perspective from Clinical Trials at the Summit, Anat Loewenstein, MD, of Tel Aviv Medical Center in Israel, discusses Axpaxli for the treatment of neovascular age-related macular degeneration.

The neutrophil-to-lymphocyte ratio appeared to distinguish between acute orbital infectious disease and noninfectious inflammation and may aid in clinical intervention, according to a study in Ophthalmic Plastic and Reconstructive Surgery.

A gene editing therapy showed safety and improvement in cone photoreceptor function in patients with CEP290-associated inherited retinal degeneration due to an IVS26 variant, according to a phase 1/2 study.

The AMA adopted new policies on broader Medicare and Medicaid health care coverage during its annual House of Delegates meeting.

Daily supplementation of lutein via marigold extract increases serum concentration to levels associated with a lower risk of developing age-related eye disease, according to study results published in Nutrients.